JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

ABT

87.15

-0.47%↓

JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

ABT

87.15

-0.47%↓

JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

ABT

87.15

-0.47%↓

JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

ABT

87.15

-0.47%↓

JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

ABT

87.15

-0.47%↓

Home・Aktien・Day One Biopharmaceuticals Inc

Day One Biopharmaceuticals Inc

Geschlossen

BrancheGesundheitswesen

21.45 -0.23

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

21.45

Max

21.45

Schlüsselkennzahlen
By Trading Economics
Einkommen	-1.6M -21M
Verkäufe	14M 54M
Gewinnspanne	-39.611
Angestellte	178
EBITDA	-3.8M -23M

Empfehlungen
By TipRanks
Empfehlungen	Neutral
12-Monats-Prognose	-3.62% downside

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	1B 2.2B
Vorheriger Eröffnungskurs	21.68
Vorheriger Schlusskurs	21.45

Nachrichtenstimmung

By Acuity

50%

180 / 347 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Very Strong Bearish Evidence

6.26 / 7.47 Unterstützung & Widerstand

Day One Biopharmaceuticals Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

5. Mai 2026, 23:43 UTC

Wichtige Nachrichtenereignisse

New Zealand's Unemployment Rate Falls in 1Q

5. Mai 2026, 23:20 UTC

Heiße Aktien

Stocks to Watch: AMD, Super Micro, Arista Networks, Freshworks

5. Mai 2026, 21:48 UTC

Ergebnisse

Suncor Energy Reports Higher 1Q Profit on Increased Oil Production

5. Mai 2026, 21:05 UTC

Akquisitionen, Fusionen, Übernahmen

Canada Antitrust Watchdog Seeks to Kibosh Keyera Deal for Plains' Canada Gas Business -- 4th Update

6. Mai 2026, 00:00 UTC

Market Talk

Canada Energy Minister Signals Energy Investments in the Pipeline -- Market Talk

5. Mai 2026, 23:39 UTC

Market Talk

Gold Rises; Trump Pauses 'Project Freedom' to See if Iran Deal Can Be Finalized -- Market Talk

5. Mai 2026, 22:26 UTC

Market Talk

AMD Data-Center Business Continues to Surge -- Market Talk

5. Mai 2026, 22:20 UTC

Market Talk

AMD's AI Revolution is Still in Early Innings, Analysts Say -- Market Talk

5. Mai 2026, 22:08 UTC

Ergebnisse

Correction to "Palantir Beats Forecasts" on May 4. -- WSJ

5. Mai 2026, 22:07 UTC

Ergebnisse

AMD Stock Soars on Strong Earnings and Growing Confidence About AI -- Barrons.com

5. Mai 2026, 21:48 UTC

Ergebnisse

Pan American Silver 1Q Adj EPS $1.09 >PAAS

5. Mai 2026, 21:48 UTC

Ergebnisse

Pan American Silver 1Q Rev $1.2B >PAAS

5. Mai 2026, 21:42 UTC

Ergebnisse

Arista Networks Beats Expectations, Offers Upside Guidance. The Stock Is Down. -- Barrons.com

5. Mai 2026, 21:38 UTC

Ergebnisse

AMD Stock Jumps on Strong Earnings and Growing Confidence About AI -- Barrons.com

5. Mai 2026, 21:30 UTC

Ergebnisse

Arista Networks Beats Expectations, Offers Upside Guidance. The Stock Is Down. -- Barrons.com

5. Mai 2026, 21:29 UTC

Ergebnisse

AMD Stock Jumps on Strong Earnings and Growing Confidence About AI -- Barrons.com

5. Mai 2026, 21:26 UTC

Ergebnisse

Strategy Posts Wider Loss as Bitcoin Holdings Hit $64 Billion. The Stock Falls. -- Barrons.com

5. Mai 2026, 21:25 UTC

Ergebnisse

Alcon Inc. 1Q EPS 39c >ALC.EB

5. Mai 2026, 21:25 UTC

Ergebnisse

Alcon Inc. 1Q Rev $2.71B >ALC.EB

5. Mai 2026, 21:24 UTC

Ergebnisse

AMD Stock Jumps on Strong Earnings and Growing Confidence About AI -- Barrons.com

5. Mai 2026, 21:18 UTC

Ergebnisse

Mistras Backs 2026 Rev $730M-$750M >MG

5. Mai 2026, 21:17 UTC

Ergebnisse

AMD Stock Jumps on Solid Earnings. AI Continues to Drive Data Center Chips. -- Barrons.com

5. Mai 2026, 21:15 UTC

Ergebnisse

Strategy Records Loss of Nearly $13 Billion as Bitcoin Continues Decline -- WSJ

5. Mai 2026, 21:12 UTC

Ergebnisse

These Stocks Are Today's Movers: Intel, PayPal, Palantir, Shopify, Micron, Duolingo, and More -- Barrons.com

5. Mai 2026, 21:11 UTC

Ergebnisse

SSR Mining 1Q Rev $581.8M >SSRM

5. Mai 2026, 21:10 UTC

Ergebnisse

SSR Mining 1Q Adj EPS $1.15 >SSRM

5. Mai 2026, 21:10 UTC

Ergebnisse

SSR Mining 1Q EPS $1.16 >SSRM

5. Mai 2026, 21:08 UTC

Ergebnisse

Arista Networks Beats Expectations, Offers Upside Guidance. The Stock Is Down. -- Barrons.com

5. Mai 2026, 21:01 UTC

Ergebnisse

Intact Financial 1Q EPS C$4.12 >IFC.T

5. Mai 2026, 21:01 UTC

Heiße Aktien

Stocks to Watch Recap: Palantir, AMD, Intel, HSBC -- WSJ

Peer-Vergleich

Kursveränderung

Day One Biopharmaceuticals Inc Prognose

Kursziel

By TipRanks

-3.62% Nachteil

12-Monats-Prognose

Durchschnitt 20.75 USD -3.62%

Hoch 21.5 USD

Tief 17 USD

Basierend auf 7 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Day One Biopharmaceuticals Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

7 ratings

Buy

Halten

Sell

Basierend auf 7 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Day One Biopharmaceuticals Inc – Dist abgegeben haben.

Technischer Score

By Trading Central

6.26 / 7.47Unterstützung & Widerstand

Recent bearish events outweigh bullish events.

All events are bullish.

All events are bearish.

Stimmung

By Acuity

180 / 347 Ranking in Gesundheitswesen

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Day One Biopharmaceuticals Inc

Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genomically defined cancers. Its lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/ refractory low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.